Patents by Inventor Joyce A. Pritchard

Joyce A. Pritchard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • RECOMBINANT AVIAN PARAMYXOVIRUS VACCINE AND METHOD FOR MAKING AND USING THEREOF
    Publication number: 20140341950
    Abstract: The present invention encompasses engineered APMV compositions or vaccines. The vaccine or composition may be a recombinant APMV composition or vaccine. The present invention encompasses methods for modifying the genome of APMV to produce recombinant APMV; modified APMV prepared by such methods; DNA and protein sequences; and methods for infecting cells and host animals with such recombinant APMV.
    Type: Application
    Filed: May 15, 2013
    Publication date: November 20, 2014
    Applicants: UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC., MERIAL LIMITED
    Inventors: Michel Bublot, Teshome Mebatsion, Joyce Pritchard, Egbert Mundt
  • RECOMBINANT HVT VECTORS EXPRESSING ANTIGENS OF AVIAN PATHOGENS AND USES THEREOF
    Publication number: 20140147457
    Abstract: The present invention provides recombinant herpesvirus of turkeys (HVT) vectors that contain and express antigens of avian pathogens, compositions comprising the recombinant HVT vectors, polyvalent vaccines comprising the recombinant HVT vectors and one or more wild type viruses or recombinant vectors. The present invention further provides methods of vaccination against a variety of avian pathogens and method of producing the recombinant HVT vectors.
    Type: Application
    Filed: November 29, 2012
    Publication date: May 29, 2014
    Applicant: Merial Limited
    Inventors: Michel Bublot, Teshome Mebatsion, Joyce Pritchard, Perry Linz
  • RECOMBINANT GALLID HERPESVIRUS 3 (MDV SEROTYPE 2) VECTORS EXPRESSING ANTIGENS OF AVIAN PATHOGENS AND USES THEREOF
    Publication number: 20140147465
    Abstract: The present invention provides recombinant Gallid herpesvirus 3 (MDV-2) vectors that contain and express antigens of avian pathogens, recombinant Gallid herpesvirus 3 (MDV-2) vectors that contain a mutated gC gene, compositions comprising the recombinant Gallid herpesvirus 3 (MDV-2) vectors, polyvalent vaccines comprising the recombinant Gallid herpesvirus 3 (MDV-2) vectors and one or more wild type viruses or recombinant vectors. The present invention further provides methods of vaccination against a variety of avian pathogens and method of producing the recombinant Gallid herpesvirus 3 (MDV-2) vectors.
    Type: Application
    Filed: November 29, 2012
    Publication date: May 29, 2014
    Applicant: Merial Limited
    Inventors: Michel Bublot, Teshome Mebatsion, Joyce Pritchard, Perry Linz
  • Modified Mareks Disease Virus, and Vaccines Made Therefrom
    Publication number: 20130251737
    Abstract: The present invention provides an effective vaccine for Marek's disease, which may be prepared using a recombinant Marek's Disease Virus (MDV), strain CVI988, having been transformed with a foreign DNA construct that includes a long terminal repeat sequence of a reticuloendotheliosis virus. This safe viral agent elicits a highly protective immune response in a chicken against virulent MDV challenge without causing a significant degree of pathogenicity. Suitable formulations of the vaccine for use in chickens include an effective immunization dosage of this novel viral agent, along with a pharmaceutically acceptable carrier or diluent.
    Type: Application
    Filed: March 15, 2013
    Publication date: September 26, 2013
    Applicant: MERIAL LIMITED
    Inventors: Joyce Pritchard, Teshome Mebatsion, Michel Bublot
  • Recombinant avian paramyxovirus vaccine and method for making and using thereof
    Patent number: 8486418
    Abstract: The present invention encompasses engineered APMV compositions or vaccines. The vaccine or composition may be a recombinant APMV composition or vaccine. The present invention encompasses methods for modifying the genome of APMV to produce recombinant APMV; modified APMV prepared by such methods; DNA and protein sequences; and methods for infecting cells and host animals with such recombinant APMV.
    Type: Grant
    Filed: August 20, 2010
    Date of Patent: July 16, 2013
    Assignees: Merial Limited, University of Georgia Research Foundation, Inc.
    Inventors: Michel Bublot, Teshome Mebatsion, Joyce Pritchard, Egburt Mundt
  • Recombinant avian influenza vaccine and uses thereof
    Patent number: 8394384
    Abstract: The present invention encompasses influenza vaccines, in particular avian influenza vaccines. The vaccine may be a subunit vaccine based on the hemagglutinin of influenza. The hemagglutinin may be expressed in plants including duckweed. The invention also encompasses recombinant vectors encoding and expressing influenza antigens, epitopes or immunogens which can be used to protect animals against influenza. It encompasses also a vaccination regimen compatible with the DIVA strategy, including a prime-boost scheme using vector and subunit vaccines.
    Type: Grant
    Filed: November 30, 2009
    Date of Patent: March 12, 2013
    Assignees: Merial Limited, Biolex Therapeutics, Inc.
    Inventors: Xuan Guo, Michel Bublot, Joyce A. Pritchard, Lynn F. Dickey
  • PRODUCTION OF HEMAGGLUTININ-NEURAMINIDASE PROTEIN IN MICROALGAE
    Publication number: 20110195480
    Abstract: The present invention is directed to recombinant microalgal cells and their use in production of heterologous hemagglutinin-neuraminidase (HN) polypeptides, as well as compositions and uses thereof.
    Type: Application
    Filed: December 28, 2010
    Publication date: August 11, 2011
    Inventors: Anne-Cécile V. Bayne, James Casey Lippmeier, Kirk Emil APT, Xuan Guo, Joyce A. Pritchard
  • RECOMBINANT AVIAN PARAMYXOVIRUS VACCINE AND METHOD FOR MAKING AND USING THEREOF
    Publication number: 20110081374
    Abstract: The present invention encompasses engineered APMV compositions or vaccines. The vaccine or composition may be a recombinant APMV composition or vaccine. The present invention encompasses methods for modifying the genome of APMV to produce recombinant APMV; modified APMV prepared by such methods; DNA and protein sequences; and methods for infecting cells and host animals with such recombinant APMV.
    Type: Application
    Filed: August 20, 2010
    Publication date: April 7, 2011
    Inventors: Michel Bublot, Teshome Mebatsion, Joyce Pritchard, Egburt Mundt
  • RECOMBINANT AVIAN INFLUENZA VACCINE AND USES THEREOF
    Publication number: 20100189731
    Abstract: The present invention encompasses influenza vaccines, in particular avian influenza vaccines. The vaccine may be a subunit vaccine based on the hemagglutinin of influenza. The hemagglutinin may be expressed in plants including duckweed. The invention also encompasses recombinant vectors encoding and expressing influenza antigens, epitopes or immunogens which can be used to protect animals against influenza. It encompasses also a vaccination regimen compatible with the DIVA strategy, including a prime-boost scheme using vector and subunit vaccines.
    Type: Application
    Filed: November 30, 2009
    Publication date: July 29, 2010
    Inventors: Xuan GUO, Michel Bublot, Joyce A. Pritchard, Lynn F. Dickey
  • Coccidial vaccine and methods of making and using same
    Publication number: 20070026023
    Abstract: The present invention relates to a vaccine for coccidiosis in chickens prepared from three attenuated Eimeria species: E. acervulina, E. maxima and E. tenella. The vaccine was similar to or superior to other anticoccidial drugs in stimulating protective immunity against coccidiosis.
    Type: Application
    Filed: February 6, 2006
    Publication date: February 1, 2007
    Inventors: Larry McDougald, Alberta Fuller, Joyce Pritchard